海角破解版

Y-27632 (Dihydrochloride)

RHO/ROCK pathway inhibitor; Inhibits ROCK1 and ROCK2

Y-27632 (Dihydrochloride)

RHO/ROCK pathway inhibitor; Inhibits ROCK1 and ROCK2

Catalog #
(Select a product)
RHO/ROCK pathway inhibitor; Inhibits ROCK1 and ROCK2
Request Pricing Request Pricing

Overview

Y-27632 is a cell-permeable, highly potent and selective inhibitor of Rho-associated, coiled-coil containing protein kinase (ROCK). Y-27632 inhibits both ROCK1 (Ki = 220 nM) and ROCK2 (Ki = 300 nM) by competing with ATP for binding to the catalytic site (Davies et al.; Ishizaki et al.).

MAINTENANCE AND SELF-RENEWAL
路 Enhances survival of human embryonic stem (ES) cells when they are dissociated to single cells by preventing dissociation-induced apoptosis (anoikis), thus increasing their cloning efficiency (Watanabe et al.).
路 Improves embryoid body formation using forced-aggregation protocols (Ungrin et al.).
路 Increases the survival of cryopreserved single human ES cells after thawing (Li et al.).
路 Blocks apoptosis of mouse ES-derived neural precursors after dissociation and transplantation (Koyanagi et al.).

REPROGRAMMING
路 Direct lineage reprogramming of fibroblasts to mature neurons, in combination with CHIR99021, RepSox, Forskolin, SP600125, G枚6983 and Valproic Acid (Hu et al.).

DIFFERENTIATION
路 Improves survival of human ES cell monolayers at the initiation of differentiation protocols (Rezania et al.)
Alternative Names
ROCK inhibitor
Cell Type
Neurons, Pluripotent Stem Cells
Species
Human, Mouse, Non-Human Primate, Other, Rat
Application
Differentiation, Expansion, Maintenance, Reprogramming, Spheroid Culture
Area of Interest
Stem Cell Biology
CAS Number
129830-38-2
Chemical Formula
C鈧佲倓H鈧傗倎N鈧僌 路 2HCl
Molecular Weight
320.3 g/mol
Purity
鈮 98%
Pathway
RHO/ROCK
Target
ROCK1, ROCK2

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Name
Catalog #
72307, 100-1044, 72304, 72308, 72302
Lot #
All
Language
English
Document Type
Product Name
Catalog #
72307, 72304, 72308, 72302
Lot #
All
Language
English
Document Type
Product Name
Catalog #
100-1044
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Resources and Publications

Publications (18)

An integrated patient-derived colon organoids platform as a functional model for nutraceutical and stress response. A. Costantino et al. iScience 2026 Jun

Abstract

Nutraceuticals are increasingly investigated for their capacity to modulate oxidative and inflammatory stress, yet preclinical testing still relies largely on immortalized cell lines or animal models that poorly recapitulate human epithelial complexity. To address this gap, we developed an integrated platform based on patient-derived colon organoids generated from non-tumoral mucosa and maintained under proliferative or differentiation conditions to model distinct epithelial states. The system combines millifluidic measurement of individual organoid mass, density, and diameter with bulk RNA sequencing and digital PCR profiling to enable multiparametric characterization. Transcriptional analysis revealed state-specific gene programs and shifts in epithelial and immune-related pathways, while biophysical measurements captured structural remodeling. In this pilot validation, a defined oxidative insult followed by nutraceutical treatment elicited coordinated transcriptional and phenotypic responses. This integrated approach provides a scalable and physiologically relevant framework for functional nutraceutical profiling and mechanistic studies of epithelial stress responses.
MECP2 mutations rewire human ESC fate and bias cortical lineage commitment M. Guillon et al. Stem Cell Reports 2026 Apr

Abstract

Rett syndrome arises from loss-of-function mutations in the X-linked chromatin regulator MECP2, yet the earliest molecular derailments in development are poorly defined. Using isogenic human embryonic stem cell (hESC) models carrying three patient-derived MECP2 mutations, we followed the transcriptome from pluripotency through neuroectoderm, neural stem/progenitor stages. Developmental stage dominated transcriptional variance, but mutants shared a secondary program enriched for synaptic-membrane and extracellular matrix genes. Single-cell/bulk profiling at the embryonic stem cell (ESC) stage revealed partial na茂ve-like drift, marked by the up-regulation of the na茂ve-enriched factor ZFP42/REX1 and related markers in MECP2-mutant lines. Among convergently dysregulated genes, the cortical determinant EMX1 showed an abnormal developmental trajectory, early repression followed by overshoot, and was consistently altered across independent Rett PSC models. Single-nucleus RNA-seq of cerebral organoids uncovered allele-specific yet convergent disturbances in cortical lineage allocation. These data chart a continuous developmental trajectory for MECP2-mutant cells and nominate na茂ve-like drift and mis-timed EMX1 expression as tractable entry points for dissecting Rett pathogenesis. Graphical abstract Highlights鈥ECP2 mutations induce an early na茂ve-like transcriptional drift in hESCs鈥MX1 shows a conserved abnormal developmental trajectory across Rett models鈥hared transcriptional programs emerge during neural induction in MECP2 mutants鈥ett cerebral organoids display mutation-specific shifts in lineage allocation In this article, Flamier and colleagues show that MECP2 mutations perturb human neurodevelopment from the pluripotent stage onward. Using isogenic hESC and organoid models, they identify an early na茂ve-like transcriptional drift, abnormal EMX1 timing, and convergent defects in cortical lineage allocation, revealing continuous developmental vulnerability in Rett syndrome.
Generation of 3D Human iPSC-Derived Multi-Cell Type Neurospheres for Studying Neuron, Astrocyte, and Microglia Crosstalk S. Wendt et al. Bio-protocol 2025 Nov

Abstract

Three-dimensional (3D) human brain tissue models derived from induced pluripotent stem cells (iPSCs) have transformed the study of neural development and disease in vitro. While cerebral organoids offer high structural complexity, their large size often leads to necrotic core formation, limiting reproducibility and challenging the integration of microglia. Here, we present a detailed, reproducible protocol for generating multi-cell type 3D neurospheres that incorporate neurons, astrocytes, and optionally microglia, all derived from the same iPSCs. While neurons and astrocytes differentiate spontaneously from neural precursor cells, generated by dual SMAD-inhibition (blocking BMP and TGF-b signaling), microglia are generated in parallel and can infiltrate the mature neurosphere tissue after plating neurospheres into 48-well plates. The system supports a range of downstream applications, including functional confocal live imaging of GCaMP6f after adeno-associated virus (AAV) transduction of neurospheres or immunofluorescence staining after fixation. Our approach has been successfully implemented across multiple laboratories, demonstrating its robustness and translational potential for studying neuron鈥揼lia interactions and modeling neurodegenerative processes.